Bermuda

Bermuda

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.52 (0.44 - 0.62) 2019 Modelled IHME
0.52 (0.44 - 0.61) 2018 Modelled IHME
0.52 (0.44 - 0.60) 2017 Modelled IHME
0.52 (0.45 - 0.60) 2016 Modelled IHME
0.53 (0.45 - 0.61) 2015 Modelled IHME
0.53 (0.45 - 0.61) 2014 Modelled IHME
0.53 (0.45 - 0.61) 2013 Modelled IHME
0.53 (0.45 - 0.61) 2012 Modelled IHME
0.53 (0.45 - 0.61) 2011 Modelled IHME
0.53 (0.45 - 0.61) 2010 Modelled IHME
0.54 (0.46 - 0.62) 2009 Modelled IHME
0.54 (0.46 - 0.63) 2008 Modelled IHME
0.55 (0.46 - 0.64) 2007 Modelled IHME
0.55 (0.47 - 0.64) 2006 Modelled IHME
0.55 (0.46 - 0.65) 2005 Modelled IHME
0.55 (0.47 - 0.65) 2004 Modelled IHME
0.55 (0.46 - 0.64) 2003 Modelled IHME
0.55 (0.46 - 0.65) 2002 Modelled IHME
0.55 (0.46 - 0.65) 2001 Modelled IHME
0.55 (0.45 - 0.65) 2000 Modelled IHME
0.55 (0.46 - 0.65) 1999 Modelled IHME
0.56 (0.46 - 0.65) 1998 Modelled IHME
0.56 (0.47 - 0.65) 1997 Modelled IHME
0.56 (0.47 - 0.65) 1996 Modelled IHME
0.56 (0.47 - 0.65) 1995 Modelled IHME
0.56 (0.47 - 0.65) 1994 Modelled IHME
0.56 (0.47 - 0.65) 1993 Modelled IHME
0.56 (0.47 - 0.65) 1992 Modelled IHME
0.56 (0.47 - 0.65) 1991 Modelled IHME
0.56 (0.47 - 0.66) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.24 (0.16 - 0.32) 2019 Modelled IHME
0.23 (0.16 - 0.31) 2018 Modelled IHME
0.23 (0.17 - 0.31) 2017 Modelled IHME
0.24 (0.17 - 0.32) 2016 Modelled IHME
0.24 (0.17 - 0.33) 2015 Modelled IHME
0.25 (0.17 - 0.33) 2014 Modelled IHME
0.25 (0.17 - 0.33) 2013 Modelled IHME
0.25 (0.17 - 0.33) 2012 Modelled IHME
0.25 (0.17 - 0.33) 2011 Modelled IHME
0.25 (0.17 - 0.33) 2010 Modelled IHME
0.25 (0.18 - 0.33) 2009 Modelled IHME
0.25 (0.18 - 0.34) 2008 Modelled IHME
0.26 (0.18 - 0.34) 2007 Modelled IHME
0.26 (0.18 - 0.35) 2006 Modelled IHME
0.27 (0.18 - 0.36) 2005 Modelled IHME
0.27 (0.18 - 0.35) 2004 Modelled IHME
0.27 (0.18 - 0.35) 2003 Modelled IHME
0.27 (0.18 - 0.35) 2002 Modelled IHME
0.26 (0.18 - 0.35) 2001 Modelled IHME
0.26 (0.18 - 0.36) 2000 Modelled IHME
0.27 (0.18 - 0.36) 1999 Modelled IHME
0.27 (0.19 - 0.36) 1998 Modelled IHME
0.27 (0.19 - 0.36) 1997 Modelled IHME
0.27 (0.19 - 0.37) 1996 Modelled IHME
0.27 (0.19 - 0.37) 1995 Modelled IHME
0.27 (0.19 - 0.37) 1994 Modelled IHME
0.27 (0.19 - 0.37) 1993 Modelled IHME
0.27 (0.19 - 0.37) 1992 Modelled IHME
0.27 (0.19 - 0.37) 1991 Modelled IHME
0.27 (0.19 - 0.37) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (16 - 31) 2017 Modelled IHME
23 (17 - 32) 2016 Modelled IHME
23 (17 - 32) 2015 Modelled IHME
23 (17 - 32) 2014 Modelled IHME
24 (17 - 32) 2013 Modelled IHME
24 (17 - 32) 2012 Modelled IHME
24 (17 - 33) 2011 Modelled IHME
24 (17 - 33) 2010 Modelled IHME
24 (17 - 33) 2009 Modelled IHME
24 (17 - 33) 2008 Modelled IHME
24 (17 - 33) 2007 Modelled IHME
24 (17 - 32) 2006 Modelled IHME
24 (17 - 32) 2005 Modelled IHME
24 (17 - 32) 2004 Modelled IHME
24 (17 - 32) 2003 Modelled IHME
23 (17 - 32) 2002 Modelled IHME
23 (17 - 32) 2001 Modelled IHME
23 (17 - 32) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
24 (17 - 32) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
24 (18 - 32) 1995 Modelled IHME
24 (18 - 32) 1994 Modelled IHME
24 (18 - 33) 1993 Modelled IHME
24 (18 - 33) 1992 Modelled IHME
24 (18 - 33) 1991 Modelled IHME
24 (18 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.65 (1.33 - 2.06) 2019 Modelled IHME
1.64 (1.34 - 2.04) 2018 Modelled IHME
1.62 (1.33 - 2.02) 2017 Modelled IHME
1.59 (1.32 - 1.96) 2016 Modelled IHME
1.56 (1.29 - 1.92) 2015 Modelled IHME
1.57 (1.29 - 1.93) 2014 Modelled IHME
1.57 (1.29 - 1.93) 2013 Modelled IHME
1.57 (1.29 - 1.94) 2012 Modelled IHME
1.58 (1.29 - 1.96) 2011 Modelled IHME
1.58 (1.29 - 1.97) 2010 Modelled IHME
1.59 (1.29 - 1.97) 2009 Modelled IHME
1.59 (1.30 - 1.96) 2008 Modelled IHME
1.6 (1.30 - 1.97) 2007 Modelled IHME
1.61 (1.31 - 1.98) 2006 Modelled IHME
1.62 (1.32 - 1.99) 2005 Modelled IHME
1.64 (1.34 - 2) 2004 Modelled IHME
1.65 (1.35 - 2.03) 2003 Modelled IHME
1.67 (1.36 - 2.07) 2002 Modelled IHME
1.69 (1.37 - 2.10) 2001 Modelled IHME
1.71 (1.38 - 2.10) 2000 Modelled IHME
1.73 (1.40 - 2.13) 1999 Modelled IHME
1.74 (1.41 - 2.16) 1998 Modelled IHME
1.76 (1.42 - 2.18) 1997 Modelled IHME
1.78 (1.44 - 2.20) 1996 Modelled IHME
1.79 (1.45 - 2.21) 1995 Modelled IHME
1.8 (1.46 - 2.23) 1994 Modelled IHME
1.81 (1.47 - 2.25) 1993 Modelled IHME
1.82 (1.47 - 2.26) 1992 Modelled IHME
1.82 (1.48 - 2.28) 1991 Modelled IHME
1.83 (1.48 - 2.29) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 30) 2018 Modelled IHME
23 (16 - 30) 2017 Modelled IHME
23 (16 - 30) 2016 Modelled IHME
23 (16 - 30) 2015 Modelled IHME
23 (16 - 30) 2014 Modelled IHME
22 (16 - 30) 2013 Modelled IHME
23 (16 - 30) 2012 Modelled IHME
23 (16 - 30) 2011 Modelled IHME
22 (16 - 30) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
22 (16 - 30) 2008 Modelled IHME
22 (16 - 30) 2007 Modelled IHME
22 (16 - 29) 2006 Modelled IHME
22 (16 - 30) 2005 Modelled IHME
22 (16 - 30) 2004 Modelled IHME
23 (16 - 30) 2003 Modelled IHME
23 (16 - 30) 2002 Modelled IHME
23 (16 - 30) 2001 Modelled IHME
23 (16 - 30) 2000 Modelled IHME
23 (16 - 30) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (16 - 30) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 30) 1995 Modelled IHME
23 (16 - 30) 1994 Modelled IHME
22 (16 - 30) 1993 Modelled IHME
22 (15 - 30) 1992 Modelled IHME
22 (15 - 29) 1991 Modelled IHME
22 (15 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Overview

Prevalence (national)

Modelled

HBV (HBsAg+)
0.52 (%)
2019
(0.44 - 0.62(%))
IHME
HCV (RNA/cAg+)
1.65 (%)
2019
(1.33 - 2.06(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2
2019
(1 - 3)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.24 (%)
2019, latest modelled
(0.16 - 0.32(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines